The prostate cancer landscape in Europe: Current challenges, future opportunities

被引：26
|
作者：
Marhold, Maximilian [1 ]
Kramer, Gero [2 ]
Krainer, Michael [1 ]
Le Magnen, Clementine [3 ,4 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Div Oncol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Urol, Vienna, Austria
[3] Univ Basel, Univ Hosp Basel, Inst Med Genet & Pathol, Pathol, Basel, Switzerland
[4] Univ Hosp Basel, Dept Urol, Basel, Switzerland
来源：
CANCER LETTERS | 2022年 / 526卷
关键词：
Prostate cancer; Treatment; Europe; ANDROGEN-DEPRIVATION THERAPY; PHASE-III TRIAL; RADICAL PROSTATECTOMY; DOUBLE-BLIND; OPEN-LABEL; PLUS PREDNISONE; DOCETAXEL; SURVIVAL; ENZALUTAMIDE; RADIOTHERAPY;
D O I：
10.1016/j.canlet.2021.11.033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prostate cancer (PCa) is the most common non-cutaneous cancer in men in Europe and is predicted to exhibit declining mortality in the European Union (EU) due to various recent improvements in treatment. The goal of this short review is to give insight into the European treatment landscape of PCa, while focusing on improvements in care.
引用
收藏
页码：304 / 310
页数：7
相关论文
共 50 条
  • [1] Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations
    Ward, Tim H.
    Gilbert, Duncan C.
    Higginbotham, George
    Morris, Chris M.
    Speirs, Valerie
    Curtin, Nicola J.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2022, 8 (01): : 3 - 13
  • [2] Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities
    Payne, Heather
    Bahl, Amit
    Mason, Malcolm
    Troup, Janis
    De Bono, Johann
    BJU INTERNATIONAL, 2012, 110 (05) : 658 - 667
  • [3] Biomarkers for prostate cancer: present challenges and future opportunities
    Sharma, Pranav
    Zargar-Shoshtari, Kamran
    Pow-Sang, Julio M.
    FUTURE SCIENCE OA, 2016, 2 (01):
  • [4] Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges
    Nixon, N. A.
    Blais, N.
    Ernst, S.
    Kollmannsberger, C.
    Bebb, G.
    Butler, M.
    Smylie, M.
    Verma, S.
    CURRENT ONCOLOGY, 2018, 25 (05) : E373 - E384
  • [5] CURRENT CHALLENGES AND FUTURE OPPORTUNITIES
    BENTLEY, DW
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1989, 10 (10): : 481 - 483
  • [6] Oligometastatic Prostate Cancer: Current Status and Future Challenges
    Jadvar, Hossein
    Abreu, Andre Luis
    Ballas, Leslie K.
    Quinn, David I.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (11) : 1628 - 1635
  • [7] Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
    Li, Huanye
    Lee, Chau Hung
    Chia, David
    Lin, Zhiping
    Huang, Weimin
    Tan, Cher Heng
    DIAGNOSTICS, 2022, 12 (02)
  • [8] Fatty acids and prostate cancer: current status and future challenges
    Pandian, SS
    Eremin, OE
    McClinton, S
    Wahle, KWJ
    Heys, SD
    JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH, 1999, 44 (06): : 352 - 361
  • [9] The future of academic radiology in Europe: challenges and opportunities
    Becker, Minerva
    Brkljacic, Boris
    EUROPEAN RADIOLOGY, 2025, 35 (02) : 559 - 561
  • [10] The Skin Microbiome: Current Landscape and Future Opportunities
    Smythe, Paisleigh
    Wilkinson, Holly N. N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
12345